Literature DB >> 17957337

Molecular basis of invasion in breast cancer.

E A McSherry1, S Donatello, A M Hopkins, S McDonnell.   

Abstract

Cancer cell invasion involves the breaching of tissue barriers by cancer cells, and the subsequent infiltration of these cells throughout the surrounding tissue. In breast cancer, invasion at the molecular level requires the coordinated efforts of numerous processes within the cancer cell and its surroundings. Accumulation of genetic changes which impair the regulation of cell growth and death is generally accepted to initiate cancer. Loss of cell-adhesion molecules, resulting in a loss in tissue architecture, in parallel with matrix remodelling may also confer a motile or migratory advantage to breast cancer cells. The tumour microenvironment may further influence the behaviour of these cancer cells through expression of cytokines, growth factors, and proteases promoting chemotaxis and invasion. This review will attempt to summarise recent work on these fundamental processes influencing or facilitating breast cancer cell invasion. (Part of a Multi-author Review).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957337     DOI: 10.1007/s00018-007-7388-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  36 in total

1.  [Expression of activated leukocyte cell adhesion molecule in breast cancer. Predictability of the response to taxane-free chemotherapy].

Authors:  E Kilic; K Milde-Langosch; V Müller; R Wirtz; M Ihnen
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

2.  The EGF signaling pathway influences cell migration and the secretion of metalloproteinases by myoepithelial cells in pleomorphic adenoma.

Authors:  Natalia Festugatto Navarini; Vera Cavalcanti de Araújo; Amy Louise Brown; Fabrício Passador-Santos; Isabela Fernandes de Souza; Marcelo Henrique Napimoga; Ney Soares Araújo; Elizabeth Ferreira Martinez
Journal:  Tumour Biol       Date:  2014-09-18

3.  Effect of epithelial growth factor on matrix metalloproteinase-2 and E-cadherin/β-catenin expression in an in situ model of tumorigenesis.

Authors:  Natalia Festugatto Navarini; Vera Cavalcanti De Araújo; Marcelo Sperandio; Marcelo Henrique Napimoga; Lucas Novaes Teixeira; Ney Soares De Araújo; Elizabeth Ferreira Martinez
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

4.  Proteinase-activated receptor 2 (PAR(2)) in cholangiocarcinoma (CCA) cells: effects on signaling and cellular level.

Authors:  Roland Kaufmann; Alexander Hascher; Franziska Mussbach; Petra Henklein; Kathrin Katenkamp; Martin Westermann; Utz Settmacher
Journal:  Histochem Cell Biol       Date:  2012-08-15       Impact factor: 4.304

5.  Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS).

Authors:  Frank He; Nora L Springer; Matthew A Whitman; Siddharth P Pathi; Yeonkyung Lee; Sunish Mohanan; Stephen Marcott; Aaron E Chiou; Bryant S Blank; Neil Iyengar; Patrick G Morris; Maxine Jochelson; Clifford A Hudis; Pragya Shah; Jennie A M R Kunitake; Lara A Estroff; Jan Lammerding; Claudia Fischbach
Journal:  Biomaterials       Date:  2019-09-11       Impact factor: 12.479

6.  In vivo assay for tumor cell invasion.

Authors:  Lorena Hernandez; Tatiana Smirnova; Jeffrey Wyckoff; John Condeelis; Jeffrey E Segall
Journal:  Methods Mol Biol       Date:  2009

7.  Regulation of cancer invasiveness by the physical extracellular matrix environment.

Authors:  Aron Parekh; Alissa M Weaver
Journal:  Cell Adh Migr       Date:  2009-07-27       Impact factor: 3.405

Review 8.  Multi-faceted role of HSP40 in cancer.

Authors:  Aparna Mitra; Lalita A Shevde; Rajeev S Samant
Journal:  Clin Exp Metastasis       Date:  2009-04-02       Impact factor: 5.150

9.  Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins.

Authors:  Remedios Castelló-Cros; David R Khan; Jeffrey Simons; Matthildi Valianou; Edna Cukierman
Journal:  BMC Cancer       Date:  2009-03-26       Impact factor: 4.430

10.  CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Authors:  Gwladys Zabouo; Anne-Marie Imbert; Jocelyne Jacquemier; Pascal Finetti; Thomas Moreau; Benjamin Esterni; Daniel Birnbaum; François Bertucci; Christian Chabannon
Journal:  Breast Cancer Res       Date:  2009-01-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.